Angle: Joseph Eid
Liquid biopsy technology company Angle has appointed Joseph Eid as a nonexecutive director. Eid is a physician who is board certified in medical oncology, hematology, and internal medicine. He most recently served as chief medical officer and head of global drug development for Luzsana Biotechnology, a subsidiary of Jiangsu Hengrui Pharmaceutical. He has also previously held senior positions in clinical development and medical affairs at Bristol Myers Squibb, Merck, and Hoffman-La Roche.
Centogene: Florian Vogel
Florian Vogel will step down as chief process officer and member of the management board of Centogene, effective Feb. 28. Until 2018, he was the company's senior director of R&D. Centogene did not announce any plans for his replacement.
Prenetics Global: Bayju Thakar
Genomic and diagnostic testing firm Prenetics Global has appointed Bayju Thakar as CEO and a board member of subsidiary Prenetics EMEA, which serves Europe, the Middle East, and Africa. Thakar has more than 20 years of experience in healthcare and digital health, mergers and acquisitions, and strategic partnerships, including as cofounder and CEO of Doctor Care Anywhere, a UK-based telehealth primary care business.
Biological Dynamics: Peter Wulff
Biological Dynamics has appointed Peter Wulff as its CFO, effective Jan. 1. He has more than 35 years of experience in financial management and was most recently CFO at JenaValve Technology. Before that he was the financial corporate officer at Alphatec Spine Holdings, Artes Medical, CryoCor, and Pure Biosciences. Based in San Diego, Biological Dynamics' ExoVerita platform isolates extracellular vesicles for multiomic applications.
Enalees: Eric Germain
Eric Germain has been appointed as managing director of French veterinary molecular diagnostics company Enalees. Previously, he held managing director and chief of staff roles at private and public institutions, including Genopole. Germain has a master's degree in biology from Université d'Orsay in Paris.
For additional recent items on executive appointments, promotions, and departures in the omics and molecular diagnostics space, please see the People in the News page on our website.